ANNEXIN II COMPOSITIONS FOR TREATING OR MONITORING INFLAMMATION OR IMMUNE-MEDIATED DISORDERS
1 Assignment
0 Petitions
Accused Products
Abstract
Methods and compositions for treating, detecting, diagnosing or assisting in the diagnosis of an inflammatory or immunological disorder are provided. The authors have made the novel discovery that anti-dsDNA antibodies are reactive to cell surface annexin II and through this interaction, anti-dsDNA antibodies are bound and then internalized and translocated into the cytoplasm and/or nucleus where they mediate altered cellular functions. Compositions that inhibit or interfere with the interaction of annexin II with anti-dsDNA antibodies can be used to treat one or more symptoms or pathological processes of an inflammatory or immunological disorder, preferably an auto-immune disorder. Methods for monitoring the progression or severity of an inflammatory or immunological disorder are also provided. In certain embodiments, levels of annexin II and/or anti-dsDNA antibodies, including anti-dsDNA antibodies that can bind to annexin II, are assessed and compared to a reference level of annexin II and/or anti-dsDNA antibodies that corresponds to a specific stage or severity of the disorder.
11 Citations
17 Claims
-
1. (canceled)
-
2. (canceled)
-
3. (canceled)
- 4. A composition for inhibiting or reducing binding of anti-DNA antibodies to cell surface annexin II and subsequent cellular internalization of anti-DNA antibodies comprising an effective amount of an inhibitory nucleic acid to down regulate cellular expression of annexin II and a sterile pharmaceutically acceptable carrier for administration to an individual in need thereof.
-
8. (canceled)
-
9. (canceled)
-
10. (canceled)
-
12. (canceled)
-
13. (canceled)
-
16. (canceled)
Specification